Cross-source evidence timeline
Efpeglenatide research timeline
Follow 7 selected, directly cited source records from February 7, 2014 through July 7, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT06174779↗
PeptideScanner retained ClinicalTrials.gov record NCT06174779 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07379333↗
PeptideScanner retained ClinicalTrials.gov record NCT07379333 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-05-13, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗
Added to PeptideScanner November 16, 2026
Source year
2025
Literature metadata
Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.↗
PubMed lists PMID 41403449 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2025-12-01 (day precision). PeptideScanner associated the retained record with the identity slug efpeglenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 1, 2025 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT01452451↗
PeptideScanner retained ClinicalTrials.gov record NCT01452451 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02075281↗
PeptideScanner retained ClinicalTrials.gov record NCT02075281 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02081118↗
PeptideScanner retained ClinicalTrials.gov record NCT02081118 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗
Added to PeptideScanner November 16, 2026
Source year
2014
Clinical trials
ClinicalTrials.gov record NCT01093729↗
PeptideScanner retained ClinicalTrials.gov record NCT01093729 at 2026-11-16T17:34:46.889Z. Its registry update date was 2014-02-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.↗
Added to PeptideScanner November 16, 2026